Position in IONS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$175,627
-$3,913 QoQ
Shares Held
2,215
-7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#379
of 510 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $3,859,296 across 14 Biotechnology names. IONS ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OMER |
Omeros Corp
|
168,750 | $1,604,812 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
56,723 | $847,441 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,127 | $559,814 | |
| 4 | ANAB |
Anaptysbio, Inc
|
5,000 | $337,500 | |
| 5 | GLSI |
Greenwich LifeSciences, Inc.
|
10,740 | $251,960 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
This page
|
2,215 | $175,627 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
2,500 | $44,925 | |
| 8 | INSM |
INSMED Inc
|
200 | $21,324 |
All Filings in IONS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,627 | 2,215 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $179,540 | 2,391 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $185,275 | 2,342 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $139,802 | 2,137 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $79,020 | 2,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $60,340 | 2,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||